Your browser doesn't support javascript.
loading
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials.
Choucair, Khalil; Morand, Susan; Stanbery, Laura; Edelman, Gerald; Dworkin, Lance; Nemunaitis, John.
  • Choucair K; Department of Internal Medicine, University of Kansas School of Medicine, Wichita, KS, USA.
  • Morand S; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
  • Stanbery L; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
  • Edelman G; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
  • Dworkin L; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
  • Nemunaitis J; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA. johnnemunaitis@gmail.com.
Cancer Gene Ther ; 27(12): 841-853, 2020 12.
Article en En | MEDLINE | ID: mdl-32341410
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article